NNVC - MCAP CO - NanoViricides, Inc.

The growth in value of NanoViricides, Inc. (NNVC) is driven by the TheraCour platform's success in creating nanopreparations and the trial results of agents against influenza and COVID-19. The confirmed price history on this chart, where capitalization is fixed at 0.04, illustrates the company's trajectory. The business is developing a system for the physical destruction of viruses via "smart traps," however, the lack of sales and its status as a developer make current margins dependent on future regulatory approvals.

Market capitalization represents the aggregate value of all a company's shares at the current moment. By analyzing the total market value of a business, an investor sees the result of the compromise between supply and demand. The metric is calculated as the product of the price of a single share and the total number of issued securities. For NanoViricides, Inc. (NNVC), this valuation reflects the market's belief in the potential of elite virologists. Innovative nanomedicine developments directly determine the dynamics of this indicator.